Create issue ticket

125 Possible Causes for Thalassospira, lucenti

Show results in: Română

  • Myopic Macular Degeneration

    Lucentis is the first FDA-approved anti-VEGF therapy to treat myopic CNV (mCNV) in the U.S.[] […] treatment for a diagnosis for dry macular degeneration, but wet macular degeneration is treated with anti-VEGF therapy using intra-ocular injections of medications like Lucentis[] […] degeneration which is currently untreatable, OR have found that your wet macular degeneration has not responded well to VEGF (anti- vascular endothilial growth factor) drugs like Lucentis[]

    Missing: Thalassospira
  • Retinal Edema

    Avastin or Lucentis Injections: Avastin and Lucentis are both anti-VEGF medications that are injected into the eye.[] […] medications in the form of eye drops, pills, or injections • Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) medication like Avastin, Eylea or Lucentis[] LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. LUCENTIS is not for everyone.[]

    Missing: Thalassospira
  • Proliferative Retinopathy

    The study also suggested that Lucentis may help prevent DME.[] Other treatments include injecting medicines in the eye such as Avastin, Lucentis, Eylea, Iluvien and Ozurdex.[] For information on financial resources to help cover the cost of Lucentis, check out the Lucentis Patient Support Program .[]

    Missing: Thalassospira
  • Macular Degeneration

    LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. LUCENTIS is not for everyone.[] Abstract This case study concerns a patient undergoing treatment for age-related macular degeneration (ARMD) by intravitreal injections of ranibizumab (Lucentis).[] RESULTS: New or persistent PCV was identified in a cohort of patients demonstrating increasing macular exudation despite regular intravitreal ranibizumab (Lucentis; Genentech[]

    Missing: Thalassospira
  • Diabetic Retinopathy

    "Lucentis represents the first major advance in the treatment of proliferative diabetic retinopathy," he added.[] Prevention of loss of visual acuity and maintaining visual acuity Lucentis comparator group Decrease in leakage from choroidal neovascularization Lucentis comparator group[] San Francisco-based Genentech developed Lucentis, which in 2012 received FDA approval for use in treating diabetic macular edema.[]

    Missing: Thalassospira
  • Central Retinal Vein Occlusion

    Macular edema Ischemic optic neuropathy Branch retinal vein occlusion Lucentis Eylea Iridodialysis[] Following one intravitreal dexamethasone implant (Ozurdex) and one ranibizumab injection (Lucentis), functional (20/20 visual acuity) and anatomic improvement was recorded[] Anti-VEGF Agents; Lucentis (Ranibizumab), Eylea (Aflibercept) and Avastin (Bevacizumab).[]

    Missing: Thalassospira
  • Macular Degeneration, Early Onset

    The most common medications that we use are called ranibizumab (Lucentis) and bevacizumab (Avastin).[] He was left with no alternative but to pay privately for Lucentis, a drug which is costing him around 2,000 per injection: "It seems inconceivable to go blind when there is[] These drugs include ranibizumab (Lucentis ), bevacizumab (Avastin ), and numerous drugs in the pharmaceutical pipeline.[]

    Missing: Thalassospira
  • Branch Retinal Vein Occlusion

    Anti-Vascular Endothelial Growth Factor (Anti-VEGF Agents)- Lucentis (Ranibizumab).[] Medications that can be injected include vascular endothelial growth factor (VEGF) inhibitors such as Lucentis (FDA approved), Eylea (FDA approved) and Avastin (used off-label[] BRIGHTER was a 24-month study randomising 455 patients to ranibizumab 0.5mg (Lucentis ), ranibizumab plus laser, or initial laser treatment with ranibizumab allowed after[]

    Missing: Thalassospira
  • Vitreoretinal Degeneration

    Intravitreal Lucentis, Macugen, Avastin and steroid injections as well as photodynamic therapy can be used for treatment.[] Research and treatment of AMD We now routinely use drugs called anti-VEGF therapies such as Lucentis, Avastin, Eyelea, and Macugen in the treatment of Wet AMD.[] Procedure Name: Lucentis Procedure Lucentis is a drug injected into the eye to treat various eye conditions, such as wet age-related macular degeneration, macular edema, and[]

    Missing: Thalassospira
  • Age-Related Macular Degeneration 13

    Lucentis [package insert]. San Francisco, CA: Genetech; 2010. 13. Haddrill M. Lucentis vs.[] The National Institute for Health and Clinical Excellence (NICE) approved Lucentis, an anti-VGEF medciation, for use in England and Wales in 2008.[] The medications are called VEGF blockers and have the brand names of Avastin, Lucentis, and Eylea.[]

    Missing: Thalassospira

Further symptoms